These injectable medications contain a form of the hormone called GLP-1, which regulates insulin production in the body, suppresses hunger signals to the brain and slows digestion, a powerful weight-loss-promoting combination
Positioning of DPP-4 Inhibitors in the Treatment Algorithm of type 2 Diabetes In 2018 the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a new joint position statement for the treatment of type 2 diabetes (70, 71)
Among the various options available, GLP-1 injections, lipo injections, and B12 injections stand out
Levocarnitine injection, USP [Drug label]
Patients also showed notable cardiometabolic improvements, including lower blood pressure, lower fasting blood sugar, and lower insulin levels